A better world - free of malaria - is the vision of the Jomaa Pharma Team.

To reach this goal Jomaa Pharma fully endorses the Global Technical Strategy for Malaria 2016 - 2030 of the World Health Organization. 

For its part Jomaa Pharma is developing a treatment (currently in phase II) to successfully fight the disease even if the parasites have developed resistance against artemisinin and its derivates, the currently recommended first line treatment. 
We are welcoming any assistance, help and backing from any party sharing our vision, either in the form of directly speeding up the market entry of our fosmidomycin combination or by engaging in one of the surrounding action areas of our Jomaa Pharma Malaria Initiative (JPMI).  

Please do not hesitate to contact us here and now:

Hamburg office: +49 (040) 61171521
Kent, UK office: +44 (0)1959 563487, 07775 593 743    
Email: david.hutchinson@jomaa-pharma.com